Back

CBCRisk-Mastectomy: A Risk Prediction Tool to Aid Contralateral Prophylactic Mastectomy Decision Making

Sajal, I. H.; Pfeiffer, R. M.; Jatoi, I.; Gail, M. H.; Cecchini, R. S.; Choudhary, P. K.; Biswas, S.

2026-05-15 surgery
10.64898/2026.05.12.26352924 medRxiv
Show abstract

Purpose: Unilateral breast cancer (BC) patients scheduled for mastectomy often choose to undergo contralateral prophylactic mastectomy (CPM), despite substantial declines in contralateral breast cancer (CBC) risk in recent decades. Models predicting absolute risk of future CBC can aid informed decision-making about CPM. CBCRisk is an existing CBC absolute risk prediction model trained on unilateral BC patients regardless of whether they had mastectomy. Here we developed CBCRisk-Mastectomy, tailored specifically to BC patients scheduled for mastectomy and considering CPM. Patients and Methods: We used data on BC patients who underwent mastectomy to treat their first BC from two nationally representative sources: Breast Cancer Surveillance Consortium (BCSC) and Surveillance, Epidemiology, and End Results (SEER) cancer registry. We imputed missing data in the BCSC sample and used conditional logistic regression models, trained on 2,660 BC patients (665 CBC cases) from BCSC, to identify predictors and estimate relative risks (RRs). These were combined with attributable risks and CBC incidence rates estimated from SEER to obtain absolute risk. Cross-validation was used to internally validate CBCRisk-Mastectomy and compare with CBCRisk. Results: CBCRisk-Mastectomy has nine predictors: first BC type, lobular carcinoma in situ status, estrogen receptor status, tumor stage, breast density, age at BC diagnosis, family history of BC, age at first birth, and body mass index. The areas under the curve and their 95% confidence intervals for 5-year predictions for CBCRisk-Mastectomy and CBCRisk were 0.62 (0.59, 0.65) and 0.58 (0.55, 0.61), respectively. Conclusions: CBCRisk-Mastectomy may aid clinicians in counseling BC patients scheduled for mastectomy, enabling improved decision-making regarding CPM.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
PLOS ONE
5266 papers in training set
Top 12%
15.5%
2
npj Breast Cancer
23 papers in training set
Top 0.1%
10.0%
3
JNCI Cancer Spectrum
10 papers in training set
Top 0.1%
6.9%
4
BMC Cancer
67 papers in training set
Top 0.2%
6.9%
5
Breast Cancer Research
36 papers in training set
Top 0.2%
4.1%
6
Scientific Reports
3612 papers in training set
Top 25%
4.1%
7
Cancers
213 papers in training set
Top 2%
3.6%
50% of probability mass above
8
International Journal of Cancer
49 papers in training set
Top 0.4%
2.9%
9
The Journal of Clinical Endocrinology & Metabolism
36 papers in training set
Top 0.3%
2.7%
10
BMJ Open
601 papers in training set
Top 8%
2.4%
11
Clinical Cancer Research
64 papers in training set
Top 0.8%
2.4%
12
Frontiers in Oncology
103 papers in training set
Top 2%
2.2%
13
JAMA Network Open
130 papers in training set
Top 2%
2.0%
14
npj Digital Medicine
118 papers in training set
Top 2%
1.8%
15
JCO Clinical Cancer Informatics
22 papers in training set
Top 0.4%
1.8%
16
Annals of Oncology
14 papers in training set
Top 0.1%
1.7%
17
Value in Health
11 papers in training set
Top 0.2%
1.4%
18
Cancer Research
130 papers in training set
Top 2%
1.4%
19
British Journal of Cancer
49 papers in training set
Top 1%
1.2%
20
eBioMedicine
183 papers in training set
Top 4%
1.2%
21
PLOS Global Public Health
344 papers in training set
Top 7%
1.1%
22
Diagnostics
50 papers in training set
Top 2%
1.1%
23
JNCI: Journal of the National Cancer Institute
19 papers in training set
Top 0.3%
1.0%
24
Biomedical Physics & Engineering Express
11 papers in training set
Top 0.3%
0.9%
25
JMIR Research Protocols
21 papers in training set
Top 1%
0.9%
26
Cancer Research Communications
51 papers in training set
Top 2%
0.9%
27
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 40%
0.9%
28
BMC Medical Informatics and Decision Making
43 papers in training set
Top 2%
0.6%
29
eLife
5828 papers in training set
Top 67%
0.6%
30
Science Translational Medicine
127 papers in training set
Top 4%
0.6%